Pasithea Therapeutics Corp.

KTTANASDAQ Capital Market·USD·Closed

KTTANASDAQ·USD·Closed

$0.46

+3.58%

$0.46

+$0.02 (3.58%)

52W Range

10thpctl

Volume

0.31×avg

Mkt Cap

3.42MUSD

P/E

-0.2TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

10thpctl

Volume

0.31×avg

Market Cap

3.42MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-40.2%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio35.40×